Conclusions
This would serve the purposes to study what has been requested over the
years and what have been completed in response to the requirements. We
consider this to be the anchor of pediatric cancer development for
current stage and can potentially provide insight on how pediatric
cancer drug development would change for the future years.
Key words: pediatric, orphan indication, written request, cancer